Table 5. Model outputs and observed values (where available)*.
| Indicator | Model outputs | Observed value |
|---|---|---|
| Human taeniasis prevalence | 3.0% | NA |
| Pig cysticercosis prevalence | 3.1% | NA |
| Overall human NCC prevalence | 16.5% | NA |
| % of adults with calcified NCC lesions | 17.2% [9–26%] | 18.8% [16.9–20.6%] |
| % of adult NCC cases with a single lesion | 74.9% [61.9–87.7%] | 66.7% [62–71%] |
| % of adult NCC cases with 11+ lesions | 0.0003% [0–0%] | 4.2% [3–7%] |
| Epilepsy prevalence among adult NCC cases | 2.0% [0–7.0%] | 0% |
| Estimated OR of having NCC (40–59 vs. 20–39 years old) | 1.7 [0.8–3.6] | 1.6 |
| Estimated OR of having NCC (60+ vs. 20–39 years old) | 2.5 [0.8–6.0] | 2.5 |
* Note that the confidence interval for model outputs relies on the assumption that the temporal variabilities of CystiAgent and CystiHuman are accurate. However, it has not yet been possible to check this using experimental data.